UDCA treatment against COVID-19: Do we have enough clinical evidence for drug repurposing?

J Intern Med. 2024 Jan;295(1):110-112. doi: 10.1111/joim.13711. Epub 2023 Aug 22.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use
  • COVID-19*
  • Drug Repositioning
  • Humans
  • SARS-CoV-2

Substances

  • Antiviral Agents